401k Plan data: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN plan

CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 401k Plan overview

Plan Name	CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN
Plan identification number	002

CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

CONSOLIDATED MEDICAL BIO-ANALY has sponsored the creation of one or more 401k plans.

Company Name: CONSOLIDATED MEDICAL BIO-ANALY

Employer identification number (EIN): 953484894

NAIC Classification: 621510
NAIC Description: Medical and Diagnostic Laboratories

Form 5500 Filing Information

Submission information for form 5500 for 401k plan CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
002 2017-01-01
002 2016-01-01
002 2015-01-01
002 2014-01-01
002 2013-01-01
002 2012-01-01 CHIN KUO FAN CHIN KUO FAN 2013-10-15
002 2011-01-01 CHINH KUO FAN 2012-07-27 CHINH KUO FAN 2012-07-27
002 2010-01-01 CHINH KUO FAN 2011-10-13 CHINH KUO FAN 2011-10-13
002 2009-01-01 CHINH KUO FAN CHINH KUO FAN 2010-07-27

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
002	2017-01-01
002	2016-01-01
002	2015-01-01
002	2014-01-01
002	2013-01-01
002	2012-01-01	CHIN KUO FAN		CHIN KUO FAN	2013-10-15
002	2011-01-01	CHINH KUO FAN	2012-07-27	CHINH KUO FAN	2012-07-27
002	2010-01-01	CHINH KUO FAN	2011-10-13	CHINH KUO FAN	2011-10-13
002	2009-01-01	CHINH KUO FAN		CHINH KUO FAN	2010-07-27

Plan Statistics for CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN

401k plan membership statisitcs for CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN

Measure Date Value
2016: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 124
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 110
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 9
Total of all active and inactive participants 2016-01-01 119
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 119
Number of participants with account balances 2016-01-01 49
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 119
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 110
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 12
Total of all active and inactive participants 2015-01-01 122
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 122
Number of participants with account balances 2015-01-01 56
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 127
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 110
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 12
Total of all active and inactive participants 2014-01-01 122
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 122
Number of participants with account balances 2014-01-01 55
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0
2013: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 130
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 105
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 15
Total of all active and inactive participants 2013-01-01 120
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 120
Number of participants with account balances 2013-01-01 59
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 0
2012: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 132
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 112
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 13
Total of all active and inactive participants 2012-01-01 125
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 125
Number of participants with account balances 2012-01-01 61
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 1
2009: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 119
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 107
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 9
Total of all active and inactive participants 2009-01-01 116
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 116
Number of participants with account balances 2009-01-01 61
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 0

Measure	Date	Value
2016: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	124
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	110
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	9
Total of all active and inactive participants	2016-01-01	119
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	119
Number of participants with account balances	2016-01-01	49
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	119
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	110
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	12
Total of all active and inactive participants	2015-01-01	122
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	122
Number of participants with account balances	2015-01-01	56
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	127
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	110
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	12
Total of all active and inactive participants	2014-01-01	122
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	122
Number of participants with account balances	2014-01-01	55
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0
2013: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	130
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	105
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	15
Total of all active and inactive participants	2013-01-01	120
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	120
Number of participants with account balances	2013-01-01	59
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	0
2012: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	132
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	112
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	13
Total of all active and inactive participants	2012-01-01	125
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	125
Number of participants with account balances	2012-01-01	61
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	1
2009: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	119
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	107
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	9
Total of all active and inactive participants	2009-01-01	116
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	116
Number of participants with account balances	2009-01-01	61
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	0

Financial Data on CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN

Measure	Date	Value
2016 : CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2016 401k financial data
Total income from all sources (including contributions)	2016-12-31	$255,128
Total of all expenses incurred	2016-12-31	$242,121
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$234,786
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$105,511
Value of total assets at end of year	2016-12-31	$1,826,719
Value of total assets at beginning of year	2016-12-31	$1,813,712
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$7,335
Total interest from all sources	2016-12-31	$59
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2016-12-31	$0
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$200,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$105,511
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$13,007
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$1,826,719
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$1,813,712
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in pooled separate accounts at end of year	2016-12-31	$1,822,583
Value of interest in pooled separate accounts at beginning of year	2016-12-31	$1,810,220
Interest earned on other investments	2016-12-31	$59
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2016-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2016-12-31	$4,136
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2016-12-31	$3,492
Net investment gain/loss from pooled separate accounts	2016-12-31	$149,558
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$234,786
Contract administrator fees	2016-12-31	$7,335
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	LEUNG ACCOUNTANCY CORPORATION
Accountancy firm EIN	2016-12-31	202016053
2015 : CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2015 401k financial data
Total income from all sources (including contributions)	2015-12-31	$72,236
Total of all expenses incurred	2015-12-31	$53,695
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$46,520
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$112,388
Value of total assets at end of year	2015-12-31	$1,813,712
Value of total assets at beginning of year	2015-12-31	$1,795,171
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$7,175
Total interest from all sources	2015-12-31	$115
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Administrative expenses professional fees incurred	2015-12-31	$6,965
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$200,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$105,069
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$7,319
Administrative expenses (other) incurred	2015-12-31	$210
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$18,541
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$1,813,712
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$1,795,171
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in pooled separate accounts at end of year	2015-12-31	$1,810,220
Value of interest in pooled separate accounts at beginning of year	2015-12-31	$1,785,853
Interest earned on other investments	2015-12-31	$115
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2015-12-31	$3,492
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2015-12-31	$9,318
Net investment gain/loss from pooled separate accounts	2015-12-31	$-40,267
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$46,520
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	LEUNG ACCOUNTANCY CORPORATION
Accountancy firm EIN	2015-12-31	202016053
2014 : CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2014 401k financial data
Total income from all sources (including contributions)	2014-12-31	$200,789
Total of all expenses incurred	2014-12-31	$115,016
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$107,930
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$91,702
Value of total assets at end of year	2014-12-31	$1,795,171
Value of total assets at beginning of year	2014-12-31	$1,709,398
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$7,086
Total interest from all sources	2014-12-31	$212
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Administrative expenses professional fees incurred	2014-12-31	$6,771
Was this plan covered by a fidelity bond	2014-12-31	No
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$91,702
Participant contributions at beginning of year	2014-12-31	$3,740
Administrative expenses (other) incurred	2014-12-31	$315
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$85,773
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$1,795,171
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$1,709,398
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in pooled separate accounts at end of year	2014-12-31	$1,785,853
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$1,681,786
Interest earned on other investments	2014-12-31	$212
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2014-12-31	$9,318
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2014-12-31	$23,872
Net investment gain/loss from pooled separate accounts	2014-12-31	$108,875
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$107,930
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	LEUNG ACCOUNTANCY CORPORATION
Accountancy firm EIN	2014-12-31	202016053
2013 : CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2013 401k financial data
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$389,933
Total of all expenses incurred	2013-12-31	$43,909
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$37,556
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$106,437
Value of total assets at end of year	2013-12-31	$1,709,398
Value of total assets at beginning of year	2013-12-31	$1,363,374
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$6,353
Total interest from all sources	2013-12-31	$371
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Administrative expenses professional fees incurred	2013-12-31	$6,038
Was this plan covered by a fidelity bond	2013-12-31	No
If this is an individual account plan, was there a blackout period	2013-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$106,179
Participant contributions at end of year	2013-12-31	$3,740
Participant contributions at beginning of year	2013-12-31	$4,051
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$258
Administrative expenses (other) incurred	2013-12-31	$315
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$346,024
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$1,709,398
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$1,363,374
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in pooled separate accounts at end of year	2013-12-31	$1,681,786
Value of interest in pooled separate accounts at beginning of year	2013-12-31	$1,339,048
Interest on participant loans	2013-12-31	$0
Interest earned on other investments	2013-12-31	$371
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2013-12-31	$23,872
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2013-12-31	$20,275
Net investment gain/loss from pooled separate accounts	2013-12-31	$283,125
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$37,556
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	LEUNG ACCOUNTANCY CORPORATION
Accountancy firm EIN	2013-12-31	202016053
2012 : CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2012 401k financial data
Unrealized appreciation/depreciation of other (non real estate) assets	2012-12-31	$0
Total unrealized appreciation/depreciation of assets	2012-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total income from all sources (including contributions)	2012-12-31	$266,817
Total loss/gain on sale of assets	2012-12-31	$0
Total of all expenses incurred	2012-12-31	$138,646
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$116,357
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$96,404
Value of total assets at end of year	2012-12-31	$1,363,374
Value of total assets at beginning of year	2012-12-31	$1,235,203
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$22,289
Total interest from all sources	2012-12-31	$1,336
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Administrative expenses professional fees incurred	2012-12-31	$22,038
Was this plan covered by a fidelity bond	2012-12-31	No
If this is an individual account plan, was there a blackout period	2012-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$88,876
Participant contributions at end of year	2012-12-31	$4,051
Participant contributions at beginning of year	2012-12-31	$8,141
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$7,528
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2012-12-31	$0
Administrative expenses (other) incurred	2012-12-31	$111
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$128,171
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$1,363,374
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$1,235,203
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Investment advisory and management fees	2012-12-31	$0
Value of interest in pooled separate accounts at end of year	2012-12-31	$1,339,048
Value of interest in pooled separate accounts at beginning of year	2012-12-31	$1,174,669
Interest earned on other investments	2012-12-31	$1,336
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2012-12-31	$20,275
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2012-12-31	$52,393
Net investment gain/loss from pooled separate accounts	2012-12-31	$169,077
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	Yes
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$116,357
Contract administrator fees	2012-12-31	$140
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	LEUNG ACCOUNTANCY CORPORATION
Accountancy firm EIN	2012-12-31	202016053

Form 5500 Responses for CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN

2016: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Insurance	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement – Insurance	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Insurance	Yes
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement – Insurance	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Insurance	Yes
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement – Insurance	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Insurance	Yes
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement – Insurance	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Insurance	Yes
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement – Insurance	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2009: CONSOLIDATED MEDICAL BIOANALYSIS, INC. 401(K) PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Insurance	Yes
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

THE LINCOLN NATIONAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65676 )
Policy contract number	GP 19175 / FPQ9
Policy instance	1
THE LINCOLN NATIONAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65676 )
Policy contract number	GP 19175 / FPQ9
Policy instance	1
THE LINCOLN NATIONAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65676 )
Policy contract number	GP 19175 / FPQ9
Policy instance	1
JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )
Policy contract number	47839
Policy instance	1
THE LINCOLN NATIONAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 65676 )
Policy contract number	GP 19175 / FPQ9
Policy instance	2

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	CONSOLIDATED MEDICAL BIO-ANALY
Employer identification number (EIN):	953484894
NAIC Classification:	621510
NAIC Description:	Medical and Diagnostic Laboratories